The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Minimal residual disease at end of induction and consolidation remain important prognostic indicators for newly diagnosed children and young adults with very high-risk (VHR) B-lymphoblastic leukemia (B-ALL): Children’s Oncology Group AALL1131.
 
Wanda L. Salzer
No Relationships to Disclose
 
Michael James Burke
No Relationships to Disclose
 
Meenakshi Devidas
Honoraria - Novartis
 
Yunfeng Dai
No Relationships to Disclose
 
Nyla A. Heerema
No Relationships to Disclose
 
Andrew J. Carroll
No Relationships to Disclose
 
Lia Gore
Employment - Anchiano (I)
Leadership - Anchiano (I); Vedantra (I)
Stock and Other Ownership Interests - Amgen; Anchiano (I); Celgene; ITOS Oncology (I); Mirati Therapeutics (I); OnKure; Sanofi
Consulting or Advisory Role - Amgen; Janssen Oncology; Novartis; OnKure; Pfizer; Roche/Genentech; Syndax
Patents, Royalties, Other Intellectual Property - Patent held for diagnostic discovery and treatment response methodology tools in the use of MR spectroscopy for leukemia.
 
Joanne M. Hilden
No Relationships to Disclose
 
Eric Larsen
No Relationships to Disclose
 
Elizabeth A. Raetz
Research Funding - Pfizer (Inst)
Other Relationship - Celgene; Celgene
 
Naomi J. Winick
No Relationships to Disclose
 
William L. Carroll
Other Relationship - Amgen
 
Stephen Hunger
Stock and Other Ownership Interests - Amgen; Merck (I)
Honoraria - Amgen
Consulting or Advisory Role - Novartis
 
Mignon L. Loh
Consulting or Advisory Role - MediSix Therapeutics
 
Brent L. Wood
Honoraria - Abbvie; Amgen; Amgen; Astellas Pharma; Janssen; Roche; Seagen
Consulting or Advisory Role - Sysmex
Research Funding - Amgen (Inst); BiolineRx (Inst); Biosight (Inst); Janssen Oncology (Inst); Juno Therapeutics (Inst); Novartis; Pfizer (Inst); Seagen (Inst); Stemline Therapeutics (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen
 
Michael J. Borowitz
Consulting or Advisory Role - Amgen
Research Funding - Becton Dickinson
Travel, Accommodations, Expenses - Beckman Coulter